Philadelphia Eagles quarterback Jalen Hurts is out indefinitely with a superficial blood clot in his calf, a diagnosis that has upended the franchise's 2026 season and raised urgent questions about how the injury was handled before last Sunday's game in London. The team announced Thursday that Hurts will miss the Week 6 matchup against the Carolina Panthers, handing the offense to third-year backup Tanner McKee.
The decision came after a follow-up ultrasound Wednesday night revealed what the Eagles described as "movement in the small blood clot" — a development that changed the entire course of treatment for the 28-year-old franchise quarterback and left his return date unknown.
A Cleat to the Calf: How the Blood Clot Was Discovered
The sequence began quietly. During Philadelphia's Week 4 loss to the Los Angeles Rams on Oct. 4, Hurts took a cleat to his calf. According to the team's statement, Hurts first reported discomfort on Oct. 8, when he requested treatment — four full days after the initial blow.
By the Saturday before the Eagles' Week 5 international game against the Jacksonville Jaguars, the blood clot had been discovered. Doctors cleared Hurts to play, and he took the field in London, completing 21 of 40 passes for 220 yards with one touchdown and no interceptions. The Eagles still lost 19-17 on a walk-off 57-yard field goal from Jaguars kicker Cam Little — their third consecutive defeat.
Two days later, the picture changed. A follow-up ultrasound showed the small clot had moved, and the Eagles made the call to sit their star. The NFL later confirmed it held pregame communications with the Eagles regarding Hurts' blood clot before the London game, a detail first reported by ProFootballTalk that has since fueled scrutiny over whether Hurts should have played at all. The Eagles have not detailed who cleared Hurts to play, only that he was medically approved to suit up.
Timeline: From a Cleat to the Calf to a Sidelined Star
The events unfolded over the span of about a week and a half:
- Oct. 4 (Week 4): Hurts is cleated in the calf during a loss to the Los Angeles Rams.
- Oct. 8: Hurts requests treatment for the calf, four days after the play.
- Oct. 10 (Saturday): The blood clot is discovered before the London game.
- Oct. 11 (Week 5): Hurts is cleared to play and starts against Jacksonville; the Eagles lose 19-17.
- Oct. 14 (Wednesday): A follow-up ultrasound reveals the clot has moved.
- Oct. 15 (Thursday): The Eagles rule Hurts out for Week 6 and name Tanner McKee the starter.
What Is a Superficial Blood Clot — and Why Does It Sideline a Quarterback?
A superficial blood clot, medically known as superficial vein thrombosis or superficial thrombophlebitis, forms in the veins just beneath the surface of the skin rather than in the deeper veins of the leg. That distinction matters: it is generally considered far less dangerous than a deep vein thrombosis (DVT) or the pulmonary embolism that can result when a clot breaks loose and travels to the lungs.
But the real danger with any clot is movement. If a clot migrates into deeper veins or toward the lungs, it can become a life-threatening emergency — which is why medical experts and the NFL treat even "small" superficial clots with caution. ESPN analyst Kirk Herbstreit, who survived a pulmonary embolism himself, stressed that a superficial blood clot is "different from a pulmonary embolism" while urging the public to take the diagnosis seriously.
The complication for a quarterback is the treatment. The standard course often includes blood-thinning medication, which is incompatible with contact sports because of the elevated bleeding risk. Experts cited by the New York Post said Hurts could be sidelined for at least 45 days if he is placed on blood thinners — roughly six to seven weeks. Vascular guidelines generally recommend about six and a half weeks of treatment for certain lower-limb clots, according to Eagles Wire. A smaller, superficial clot can sometimes resolve with rest alone, which would dramatically shorten that window.
Doctors interviewed by NJ.com described small superficial clots as typically "not serious" in a normal recovery, noting they often heal with rest and monitoring. That uncertainty — blood thinners versus rest — is exactly what makes Hurts' return date so difficult to pin down.
Where Things Stand Now: No IR, No Timetable
As of Friday, the Eagles are not planning to place Hurts on injured reserve, according to ESPN's Adam Schefter and NFL Network's Ian Rapoport. That decision leaves open the possibility he could return within the next month, rather than the minimum four-game absence an IR designation would require. But the team has offered no firm timetable, and Hurts has been described only as "out indefinitely."
The broader context is grim for Philadelphia. At 2-3, the Eagles sit below .500 for the first time since Nick Sirianni's debut season in 2021, having dropped three straight games. Hurts had thrown for 933 yards and eight touchdowns through five games, and he is in the middle of a five-year, $255 million contract that runs through 2028 — with more than $179 million in total guarantees. The Associated Press reported that his guaranteed money is set to drop in the coming years, making his long-term health a franchise-level concern that stretches well beyond a single Sunday.
What Happens Next for Hurts and the Eagles
The immediate answer is Tanner McKee. The 2023 sixth-round pick out of Stanford will make his third career start Sunday against the Carolina Panthers, stepping in for a two-time Pro Bowl quarterback who owns a Super Bowl ring. McKee has appeared in six games over his career, completing 54 of 88 passes (61.4 percent) for 597 yards, five touchdowns and one interception.
Beyond Sunday, the Eagles' path depends entirely on how Hurts' body responds to treatment. If he is prescribed blood thinners, the realistic outlook points toward a mid-to-late November return. If the clot resolves with rest and monitoring alone, he could be back sooner. Either way, Philadelphia will have to balance urgency — a 2-3 team fighting to stay in the NFC playoff picture — against the long-term health of its most important player and largest financial investment.
The Bottom Line: Key Takeaways
- Jalen Hurts is out indefinitely with a superficial blood clot in his calf.
- The clot was discovered before the London game, but Hurts was cleared to play; the Eagles lost 19-17 to Jacksonville.
- A Wednesday night ultrasound showed the clot had moved, prompting the Week 6 ruling.
- Treatment — likely blood thinners — will determine the timeline, with estimates ranging from a few weeks to 45-plus days.
- Tanner McKee starts Sunday against the Carolina Panthers.
- The Eagles are not planning to place Hurts on injured reserve.
